IBEX LTD (IBEX) Stock Fundamental Analysis
USA - NASDAQ:IBEX - BMG4690M1010 - Common Stock
40.94 USD
-1.06 (-2.52%)
40.94 USD
0 (0%)
Taking everything into account, IBEX scores 6 out of 10 in our fundamental rating. IBEX was compared to 86 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. IBEX is growing strongly while it is still valued neutral. This is a good combination! With these ratings, IBEX could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
In the past 5 years IBEX has always been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
IBEX has a Return On Assets of 13.49%. This is amongst the best in the industry. IBEX outperforms 93.02% of its industry peers.
IBEX has a Return On Equity of 27.45%. This is amongst the best in the industry. IBEX outperforms 90.70% of its industry peers.
IBEX has a Return On Invested Capital of 20.43%. This is amongst the best in the industry. IBEX outperforms 93.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROIC | 20.43% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
IBEX has a Profit Margin of 6.60%. This is in the better half of the industry: IBEX outperforms 69.77% of its industry peers.
In the last couple of years the Profit Margin of IBEX has grown nicely.
IBEX's Operating Margin of 8.71% is fine compared to the rest of the industry. IBEX outperforms 63.95% of its industry peers.
In the last couple of years the Operating Margin of IBEX has grown nicely.
With a Gross Margin value of 30.91%, IBEX perfoms like the industry average, outperforming 40.70% of the companies in the same industry.
IBEX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
IBEX has an Altman-Z score of 5.48. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
IBEX has a Altman-Z score of 5.48. This is in the better half of the industry: IBEX outperforms 76.74% of its industry peers.
IBEX has a debt to FCF ratio of 0.06. This is a very positive value and a sign of high solvency as it would only need 0.06 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.06, IBEX belongs to the best of the industry, outperforming 95.35% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
IBEX has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. IBEX outperforms 83.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 5.48 |
ROIC/WACC2.17
WACC9.43%
2.3 Liquidity
IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IBEX (1.82) is comparable to the rest of the industry.
IBEX has a Quick Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
IBEX has a Quick ratio of 1.82. This is comparable to the rest of the industry: IBEX outperforms 58.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.08% over the past year.
Measured over the past years, IBEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.04% on average per year.
The Revenue has grown by 9.78% in the past year. This is quite good.
The Revenue has been growing slightly by 6.62% on average over the past years.
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
3.2 Future
Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.29% on average per year.
IBEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.28% yearly.
EPS Next Y11.65%
EPS Next 2Y11.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.62, IBEX is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of IBEX indicates a somewhat cheap valuation: IBEX is cheaper than 79.07% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. IBEX is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 13.10, the valuation of IBEX can be described as correct.
77.91% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
IBEX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.62 | ||
| Fwd PE | 13.1 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBEX is valued cheaply inside the industry as 86.05% of the companies are valued more expensively.
69.77% of the companies in the same industry are more expensive than IBEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.06 | ||
| EV/EBITDA | 8.32 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.25
PEG (5Y)0.36
EPS Next 2Y11.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.94
-1.06 (-2.52%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners94.1%
Inst Owner Change4.61%
Ins Owners9.07%
Ins Owner Change-3.97%
Market Cap547.37M
Analysts45.71
Price Target39.27 (-4.08%)
Short Float %1.1%
Short Ratio0.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)10.89%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)13.65%
Min EPS beat(4)7.33%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)11.1%
EPS beat(12)10
Avg EPS beat(12)14.9%
EPS beat(16)11
Avg EPS beat(16)6.92%
Revenue beat(2)2
Avg Revenue beat(2)6.82%
Min Revenue beat(2)5.12%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.42%
Min Revenue beat(4)1.58%
Max Revenue beat(4)8.52%
Revenue beat(8)4
Avg Revenue beat(8)1.31%
Revenue beat(12)4
Avg Revenue beat(12)-0.58%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)26.23%
PT rev (3m)26.23%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.78%
EPS NY rev (1m)0%
EPS NY rev (3m)1.18%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.62 | ||
| Fwd PE | 13.1 | ||
| P/S | 0.98 | ||
| P/FCF | 20.06 | ||
| P/OCF | 11.99 | ||
| P/B | 4.08 | ||
| P/tB | 4.48 | ||
| EV/EBITDA | 8.32 |
EPS(TTM)2.8
EY6.84%
EPS(NY)3.13
Fwd EY7.64%
FCF(TTM)2.04
FCFY4.99%
OCF(TTM)3.42
OCFY8.34%
SpS41.76
BVpS10.05
TBVpS9.13
PEG (NY)1.25
PEG (5Y)0.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.49% | ||
| ROE | 27.45% | ||
| ROCE | 25.17% | ||
| ROIC | 20.43% | ||
| ROICexc | 22.19% | ||
| ROICexgc | 23.83% | ||
| OM | 8.71% | ||
| PM (TTM) | 6.6% | ||
| GM | 30.91% | ||
| FCFM | 4.89% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 106.63% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 29.77 | ||
| Cash Conversion | 69.33% | ||
| Profit Quality | 74.04% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 5.48 |
F-Score8
WACC9.43%
ROIC/WACC2.17
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.08%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%50%
EPS Next Y11.65%
EPS Next 2Y11.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.78%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%18.15%
Revenue Next Year10.8%
Revenue Next 2Y8.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.91%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year59.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.92%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y27.21%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%